glp-1 therapies success rate Chart: 1 in 8 Americans Now Use Drugs for Weight Loss GLP-1 Medications for Weight Loss:

Lyons et al

All trials were multinational and sponsored by industry (two by Sanofi Aventis, three by Novo Nordisk, one by Eli Lilly, one by AstraZeneca, one by GlaxoSmithKline)

Several studies found that GLP-1RAs might have direct effects on adipogenesis, lipotoxicity, fatty acid oxidation, cytokines related to hepatitis and fibrosis, and intestinal microbiota (193, 195)

Key Segments Analyzed Route of Administration: Parenteral administration is projected to dominate, capturing 80% of the market share by 2026

In another study, IL-1 was found to be significantly elevated in the human sigmoid circular smooth muscle layer taken from patients with UC and that the circular smooth muscle from these samples does not contract normally